Westminster Health Forum

Cardiovascular disease in England - prevention, innovation and tackling inequalities

Morning, Tuesday, 26th November 2019

Central London


This seminar will consider the opportunities and challenges for improving cardiovascular disease outcomes in England - looking at prevention, innovation in treatment and management, and improving the delivery of care.

It takes place in light of:

We expect further discussion on research and innovation in the diagnosis, treatment and management of cardiovascular disease, looking at funding for research and opportunities for increasing public and patient engagement.

Following the announcement of £79m government investment in the Accelerating Detection of Disease programme, delegates will assess the role of technology and artificial intelligence in improving diagnosis rates.

Attendees will also consider what support can be provided to innovators to scale up, in the context of the AAC, including accelerating the regulatory process, clarifying the evidence required to prove effectiveness and increasing the uptake of innovations in the NHS.

The seminar is timed following the recently announced review of the NHS Health Check Service, and will provide an opportunity to explore personalised approaches to cardiovascular disease prevention, including the use of data to target interventions, introducing genomic testing, and offering digital checks to increase uptake.

Delegates will further assess the priorities outlined in Health Matters for delivering the ambitions, including the need for routine data collection on health inequalities and cardiovascular disease risk assessments, and whole system collaboration across primary and secondary care, local authorities and the third sector.

The agenda also includes sessions on the role of Primary Care Networks in prevention, in light of the national CVD prevention audit.

Further discussion is expected on improving the delivery of care for cardiovascular disease to meet the goals of the Long Term Plan including the development of multidisciplinary teams, the role of technology and opportunities for personalised support.

Keynote Speaker

Professor Jamie Waterall

National Lead, Cardiovascular Disease Prevention and Deputy Chief Nurse, Public Health England

Keynote Speakers

Dr Matt Kearney

National Clinical Director, Cardiovascular Disease Prevention, NHS England

Professor Jamie Waterall

National Lead, Cardiovascular Disease Prevention and Deputy Chief Nurse, Public Health England

Dr Paul Chrisp

Director, Centre for Guidelines, NICE


Glyn Davies MP

Vice Chair, All-Party Parliamentary Group on Atrial Fibrillation


Dr Rani Khatib

Consultant Pharmacist in Cardiology and Cardiovascular Clinical Research, Leeds Teaching Hospitals NHS Trust

Dr Paul Clift

Consultant Cardiologist, University Hospitals Birmingham NHS Foundation Trust and National Speciality Lead for Cardiovascular Disease, National Institute of Health Research Clinical Research Network

Nick Hartshorne-Evans

Chief Executive Officer, The Pumping Marvellous Foundation